Albany accelerates future of DNA manufacturing, again
By GREGORY ZELLER // A modest state investment will help push a Long Island bioscience pioneer toward the brink of a DNA-manufacturing revolution. Through its Excelsior Jobs Program and chunky…
By GREGORY ZELLER // A modest state investment will help push a Long Island bioscience pioneer toward the brink of a DNA-manufacturing revolution. Through its Excelsior Jobs Program and chunky…
By GREGORY ZELLER // A new federal law governing Chinese imports bodes very well for a leading Long Island innovator. Stony Brook-based Applied DNA Sciences – a DNA-based supply-chain authenticator that’s…
By GREGORY ZELLER // New vaccines produced in part by a progressive Long Island biotech could significantly increase the efficacy of existing cancer treatments. The potential breakthrough – detailed this…
By GREGORY ZELLER // Every human being deserves respect – even humans who walked the Earth 10,000 years ago. So says an international assemblage of modern-day scientists – more than…
By GREGORY ZELLER // Mark another impressive victory for LineaRX, this time in a two-front battle against cancer. The Stony Brook-based biotech with innovation in its DNA (literally) has lent…